Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joern Toedling

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
JCI Insight|April 19, 2019
Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastomaIan C MacArthur, Yi Bei, Heathcliff Dorado Garcia, et al.
The Journal of Molecular Diagnostics : JMD|August 29, 2020
Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR ReactionConstantin Peitz, Annika Sprüssel, Rasmus B Linke, et al.
Plos Computational Biology|November 4, 2021
Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistanceMathurin Dorel, Bertram Klinger, Tommaso Mari, et al.
Iscience|June 18, 2021
RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescenceJoseph L Regan, Dirk Schumacher, Stephanie Staudte, et al.
Molecular Cancer Therapeutics|August 18, 2018
Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of ResistanceMaria Quanz, Eckhard Bender, Charlotte Kopitz, et al.
Iscience|June 20, 2022
Identification of a neural development gene expression signature in colon cancer stem cells reveals a role for <i>EGR2</i> in tumorigenesisJoseph L Regan, Dirk Schumacher, Stephanie Staudte, et al.
Iscience|December 5, 2024
Copy-number dosage regulates telomere maintenance and disease-associated pathways in neuroblastomaMartin Burkert, Eric Blanc, Nina Thiessen, et al.
Journal of Clinical Medicine|October 26, 2024
Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses AngiogenesisAnnika Sprüssel, Takayoshi Suzuki, Naoki Miyata, et al.
Cell Genomics|October 23, 2023
Mutational topography reflects clinical neuroblastoma heterogeneityElias Rodriguez-Fos, Mercè Planas-Fèlix, Martin Burkert, et al.
International Journal of Cancer|July 16, 2019
Reflection of neuroblastoma intratumor heterogeneity in the new OHC-NB1 disease modelTheresa M Thole, Joern Toedling, Annika Sprüssel, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
JCI Insight|April 19, 2019
Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastomaIan C MacArthur, Yi Bei, Heathcliff Dorado Garcia, et al.
The Journal of Molecular Diagnostics : JMD|August 29, 2020
Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR ReactionConstantin Peitz, Annika Sprüssel, Rasmus B Linke, et al.
Plos Computational Biology|November 4, 2021
Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistanceMathurin Dorel, Bertram Klinger, Tommaso Mari, et al.
Iscience|June 18, 2021
RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescenceJoseph L Regan, Dirk Schumacher, Stephanie Staudte, et al.
Molecular Cancer Therapeutics|August 18, 2018
Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of ResistanceMaria Quanz, Eckhard Bender, Charlotte Kopitz, et al.
Iscience|June 20, 2022
Identification of a neural development gene expression signature in colon cancer stem cells reveals a role for <i>EGR2</i> in tumorigenesisJoseph L Regan, Dirk Schumacher, Stephanie Staudte, et al.
Iscience|December 5, 2024
Copy-number dosage regulates telomere maintenance and disease-associated pathways in neuroblastomaMartin Burkert, Eric Blanc, Nina Thiessen, et al.
Journal of Clinical Medicine|October 26, 2024
Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses AngiogenesisAnnika Sprüssel, Takayoshi Suzuki, Naoki Miyata, et al.
Cell Genomics|October 23, 2023
Mutational topography reflects clinical neuroblastoma heterogeneityElias Rodriguez-Fos, Mercè Planas-Fèlix, Martin Burkert, et al.
International Journal of Cancer|July 16, 2019
Reflection of neuroblastoma intratumor heterogeneity in the new OHC-NB1 disease modelTheresa M Thole, Joern Toedling, Annika Sprüssel, et al.
Pageof 4